3rd Quarter - Report
CAPITOL HILL CONSULTING GROUP for DFB PHARMACEUTICALS INC
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
General Pharmaceutical Issues pertaining to the company. No specific legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| DAVID THOMPSON | — |
Health Issues HCR
General healthcare issues related to pharmaceutical products. Federal, Food, Drug and Cosmetic Act (21 USC 9)
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| DAVID THOMPSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.